Category
Cariprazine
CAS Number
NA
Molecular Formula
C₁₉H₂₈Cl₂N₄O
Molecular Weight
415.36 g/mol
Catalogue Number
MLS-CPZ-IMP-2
Synonym

4-(2, 3-dichlorophenyl)-1-(2-((1R, 4R)-4-ureidocyclohexyl) ethyl) piperazine 1-oxide; Cariprazine N-oxide Impurity 2

Keywords
Neurochemicals
Fine Chemicals
Aromatics
Pharmaceutical Standards
Heterocycles
Intermediates
High-Quality Pharmaceutical Reference Standards
Impurities Manufacturer in India
Impurities manufacturer and Suppliers in Hyderabad india
Slide_1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Cariprazine Urea N-Oxide Impurity (CAS No.:NA) is a high-purity pharmaceutical reference standard with the molecular formula C₁₉H₂₈Cl₂N₄O and a molecular weight of 415.36 g/mol, designed to support quality control, method development, impurity profiling, stability studies, and synthesis research and development for cariprazine-related drug substances and drug products. As a leading manufacturer and supplier in India, Manasa Life Sciences provides this impurity with comprehensive analytical documentation, including HPLC, LC-MS, NMR, and FTIR reports, along with a potency-based Certificate of Analysis (CoA); additional GC and TGA testing can be provided as per customer requirements. All products are manufactured and supplied in compliance with stringent regulatory guidelines, including ICH, EMA, EP, USP, GLP, and GDP, ensuring reliable performance for expert scientists working in pharmaceutical QC laboratories, analytical method validation, LC-MS impurity identification, and advanced synthesis R&D.